专利号:US-7041479-B2 优先权日:2000-09-06 标题 :Enhanced in vitro synthesis of active proteins containing disulfide bonds 发明人:SWARTZ JAMES ROBERT; KIM DONG-MYUNG 权利人:TRUSTESS OF THE LELAND STANFOR 摘要:Compositions and methods are provided for the enhanced in vitro synthesis of polypeptides containing disulfide bonds. In order to improve the performance of in vitro protein synthesis reactions, pre-treatment and redox buffering of the reaction mix is performed in order to optimize the redox potential. Exogenous enzymes that enhance protein folding and disulfide bond formation may also be added to the reaction.
专利号:US-2012130699-A1 优先权日:2010-11-22 标 题 :Method of molecular design and synthesis of therapeutic and preventive drugs 发明人:MARTYNOV ARTUR; FARBER BORIS S; FARBER SONYA SOPHYA 权利人:MARTYNOV ARTUR; FARBER BORIS S; FARBER SONYA SOPHYA 摘要:Industrial Application: This invention may be used in human and veterinary medicine for the design (creation and synthesis) of therapeutic and preventive drugs that are effective for the treatment of oncological and viral human and animal illnesses and for the design of new medicines. n Summary of the Invention: A new method of design and synthesis of therapeutic and preventive drugs in which a biopolymer target (protein, DNA, RNA, or a mixture of these) is used, and in the capacity of a ligand, the same biopolymer target is used, which is cut into oligomer fragments (nucleases, synthetic nucleases, and proteases); the fragments are modified through changing their charges to the opposite charge (acylation of anhydrides of dicarbonate acids or alkylation with halogen-carbonic acids). Also in the capacity of a ligand, the same biopolymer target is used, which is modified by partially changing the molecules' charges to the opposite with the creation of supramolecular biopolymer assemblies. We used supramolecule assemblies made from oligomers that were products of the hydrolysis of biopolymers, but with a change of the charge of the molecules to the opposite charge, as well as the partial change of the charges of the target biopolymers. n Technical Result: A method of molecular design and synthesis of new, unique therapeutic and preventive drugs based on self-organizing systems. The application of the method will allow a significant cut to expenditures on the design and synthesis of new drugs, expand the activity spectra of existing protein gene-engineered drugs, and create new classes of dynamic therapeutic and preventive drugs that self-adapt to the organism and target.
专利号:US-7910623-B2 优先权日:2005-07-22 标 题 :Synthesis of scabronines and analogues thereof 发明人:DANISHEFSKY SAMUEL J; WATERS STEPHEN P 权利人:SLOAN KETTERING INST CANCER 摘要:A novel synthesis of scabronines, which are related to a broader class of angularly fused tricyclic diterpenoids known as cyathanes, is provided. Scabronine G, its methyl ester derivative, and other analogs have been shown to have neurotrophic activity. Therefore, these compounds are particularly useful in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's diseases, etc. The invention provides for the synthesis of scabronines as well as analogs thereof. Pharmaceutical compositions and method of using the inventive compounds are also provided.
专利号:US-2014220556-A1 优先权日:2013-02-06 标题 :Method of Design and Synthesis of a New Drug 发明人:MARTYNOV ARTUR; FARBER BORIS S; FARBER SONYA SOPHYA 权利人:MARTYNOV ARTUR; FARBER BORIS S; FARBER SONYA SOPHYA 摘要:A method of design and synthesis of a new drug. This invention may be used in human and veterinary medicine for the design of new drugs that are effective in the treatment of oncological and viral human and animal illnesses and for the design of new medicines. In the method a biopolymer target for the drug action is selected; then the quantity of nitrogen-containing positively charged groups available for modification is calculated. Biopolymer target may be cut into oligomer fragments. Some of calculated nitrogen-containing positively charged groups are substituted with negatively charged groups by combinatorial modification. The obtained supramolecular assemblies are used as drug for the biopolymer target.
专利号:US-7384739-B2 优先权日:2001-11-14 标题 :Compositions for enhancing DNA synthesis, DNA polymerase-related factors and utilization thereof 发明人:KITABAYASHI MASAO; KUROITA TOSHIHIRO; ISHIDA YOSHIKAZU; KOMATSUBARA HIDEYUKI; NISHIYA YOSHIAKI; OKA MASANORI; KAWAMURA YOSHIHISA; IMANAKA TADAYUKI 权利人:TOYO BOSEKI 摘要:The invention provides methods, kits, and compositions for enhancing synthesis of DNA involving a carboxylate ion-supplying substance that is effective in promoting DNA synthesis in enzymatic DNA synthesis reactions. The invention further provides a thermostable DNA polymerase-related factor derived from Thermococcus species, which has an activity to promote the DNA synthesis activity of DNA polymerase or which binds to DNA polymerase.
专利号:WO-9614060-A1 优先权日:1994-11-04 标题 :Use of receptor agonists to stimulate superoxide dismutase activity 发明人:MARKLUND STEFAN L; STRAALIN PONTUS 权利人:MARKLUND STEFAN L; STRAALIN PONTUS 摘要:The present invention relates to the use of a substance for the manufacture of a composition for stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells. In particular, the invention relates to the use of a substance for the manufacture of a composition for prophylaxis or treatment of a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical. Further, the invention relates to a method for determining the effect of a substance with respect to stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells and to substances which have been selected by said method. Within the scope of the invention is a method of preventing, diminishing, controlling or inhibiting a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical in a patient who has been established to have a high risk of developing a such disease or disorder, or who has developed a such disease or disorder, the method comprising administering an effective amount of a substance which is capable of stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells.
1: Junlei Y, Wang L, Shen R, He J, Li S, Wang H, Cheng Z. The influence of cigR gene on the pathogenicity of Salmonella paratyphi A in vitro and in vivo. FEMS Microbiol Lett. 2024 Aug 20:fnae067. doi: 10.1093/femsle/fnae067. Epub ahead of print. 22(8):e3002779. doi: 10.1371/journal.pbio.3002779. Epub ahead of print. 133:155926. doi: 10.1016/j.phymed.2024.155926. Epub ahead of print. 12(4):e004181. doi: 10.1136/bmjdrc-2024-004181. 14(15):1286. doi: 10.3390/nano14151286.
合成参考文献
参考文献:10.1080/01635580903285080 摘要:Liu D, Kim DH, Park JM, Na HK, Surh YJ. Piceatannol inhibits phorbol ester-induced NF-kappa B activation and COX-2 expression in cultured human mammary epithelial cells. Nutr Cancer. 2009;61(6):855–63. doi: 10.1080/01635580903285080. 参考文献:10.4110/in.2009.9.6.274 摘要:Ramesh TP, Kim YD, Kwon MS, Jun CD, Kim SW. Swiprosin-1 Regulates Cytokine Expression of Human Mast Cell Line HMC-1 through Actin Remodeling. Immune Netw. 2009 Dec;9(6):274–84. 参考文献:10.1007/s10534-010-9301-9 摘要:Tian H, Maddox IS, Ferguson LR, Shu Q. Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems. Biometals. 2010 Jun;23(3):589–92. doi: 10.1007/s10534-010-9301-9. 参考文献:10.1111/j.1476-5381.2011.01593.x 摘要:Bardelli C, Amoruso A, Federici Canova D, Fresu L, Balbo P, Neri T, Celi A, Brunelleschi S. Autocrine activation of human monocyte/macrophages by monocyte‐derived microparticles and modulation by PPARγ ligands. British J Pharmacology. 2012 Jan 10;165(3):716–28. doi: 10.1111/j.1476-5381.2011.01593.x. 参考文献:10.1186/ar3345 摘要:Decker P. Neutrophils and interferon-α-producing cells: who produces interferon in lupus Arthritis Res Ther. 2011 Jul 06;13(4):118.